Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P42771: Variant p.Val59Gly

Cyclin-dependent kinase inhibitor 2A
Gene: CDKN2A
Feedback?
Variant information Variant position: help 59
Type of variant: help LP/P [Disclaimer]
Residue change: help From Valine (V) to Glycine (G) at position 59 (V59G, p.Val59Gly).
Physico-chemical properties: help Change from medium size and hydrophobic (V) to glycine (G)
BLOSUM score: help -3
Variant description: help In CMM2.
Other resources: help


Sequence information Variant position: help 59
Protein sequence length: help 156
Location on the sequence: help NAPNSYGRRPIQVMMMGSAR V AELLLLHGAEPNCADPATLT
Residue conservation: help
Human                         NAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCADPATLT

Mouse                         NAPNSFGRTPIQVMMMGNVHVAALLLNYGADSNCEDPTTFS

Rat                           NAPNTFGRTPIQVMMMGNVKVAALLLSYGADSNCEDPTTLS

Sequence annotation in neighborhood: help
TypePositionsDescription
Chain 1 – 156 Cyclin-dependent kinase inhibitor 2A
Repeat 44 – 72 ANK 2
Alternative sequence 52 – 116 MMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVD -> GRGSAAGAGDGGRLWRTKFAGELESGSASILRKKGRLPGEFSEGVCNHRPPPGDALGAWEAKEEE. In isoform 3.
Helix 57 – 64



Literature citations
CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.
Ruiz A.; Puig S.; Malvehy J.; Lazaro C.; Lynch M.; Gimenez-Arnau A.M.; Puig L.; Sanchez-Conejo J.; Estivill X.; Castel T.;
J. Med. Genet. 36:490-493(1999)
Cited for: VARIANTS CMM2 GLY-59; TYR-84; TRP-87 AND TRP-101;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.